Copper Peptides vs Palmitoyl Tetrapeptide-7
A side-by-side research comparison of Copper Peptides and Palmitoyl Tetrapeptide-7 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Copper Peptides | Palmitoyl Tetrapeptide-7 |
|---|---|---|
| Full name | Copper Peptide Complex (AHK-Cu, GHK-Cu variants) | Palmitoyl Tetrapeptide-7 (Pal-GQPR) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Copper peptides deliver bioavailable copper to tissues while the peptide provides signaling to stimulate collagen I/III synthesis, attract immune cells for remodeling, and promote glycosaminoglycan production. | Inhibits IL-6 release from keratinocytes and reduces inflammation-mediated MMP activation, preserving existing collagen while complementing Pal-GHK collagen building. |
| Molecular weight | 340-410 Da (varies) | 693 Da |
| Half-life | 2-4 hours | 8-12 hours (topical) |
| Bioavailability | High (topical penetration) | Good (topical) |
| Typical dose | 1-3% topical solution | 2-4% in formulation |
| Frequency | 1-2x daily | 1-2x daily |
| Route | Topical | Topical |
Copper Peptides reported benefits
- Collagen stimulation
- Wound healing
- Anti-wrinkle effects
- Skin firming
- Hair follicle support
- Antioxidant
Palmitoyl Tetrapeptide-7 reported benefits
- Anti-inflammatory (skin)
- Reduces IL-6
- Prevents collagen degradation
- Combats inflammaging
Related comparisons
Research and educational reference only. Not medical advice.